Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Yupelri ingredients?

See the DrugPatentWatch profile for Yupelri

What is Yupelri and What Does it Contain?


Yupelri is a medication approved for the treatment of chronic obstructive pulmonary disease (COPD) [1]. It is delivered via a nebulizer and contains the active ingredient revealed as triple-drug combination therapy [1]. Specifically, it is a combination of commonly prescribed inhaled medications for COPD [1]. The formulation consists of three distinct active pharmaceutical ingredients (APIs) [1].

What Are the Specific Ingredients in Yupelri?


The active ingredients in Yupelri are [1]:

* An inhaled corticosteroid (ICS)
* A long-acting beta-agonist (LABA)
* A long-acting muscarinic antagonist (LAMA)

These three classes of medications are frequently used together in the management of COPD to address its multifaceted nature.

How Does Yupelri Work for COPD?


The combination of an ICS, LABA, and LAMA in Yupelri offers a multi-pronged approach to managing COPD symptoms and exacerbations. Inhaled corticosteroids help reduce inflammation in the airways. Long-acting beta-agonists work to relax and widen the airways, making breathing easier. Long-acting muscarinic antagonists also help to open up the airways by blocking certain nerve signals. By combining these three mechanisms, Yupelri aims to provide comprehensive bronchodilation and anti-inflammatory effects [1].

Are There Other COPD Treatments Similar to Yupelri?


Yes, other COPD treatment regimens utilize combinations of ICS, LABA, and LAMA, often administered through separate inhalers. However, Yupelri is formulated as a single solution for nebulization, offering a different delivery method and potentially simplifying the treatment regimen for some patients [1].

When Does Yupelri's Patent Protection Expire?


Information regarding the specific patent expiry dates for Yupelri is available through specialized patent tracking resources. DrugPatentWatch.com provides detailed patent information, including expiry timelines for various pharmaceuticals [2].

What Are the Potential Risks or Side Effects of Yupelri?


As with any medication, Yupelri carries potential risks and side effects. Common side effects may include nasopharyngitis (common cold symptoms), oropharyngeal pain, and diarrhea [1]. More serious side effects can occur, and patients should discuss these with their healthcare providers.

---
Sources:

[1] https://www.yupelri.com/
[2] https://drugpatentwatch.com/



Other Questions About Yupelri :

yupelri nebulizer solution prices of yupelri evaluate the pharmaceuticals company sandoz on yupelri yupelri 175 mcg/3 ml solution yupelri ingredients Yupelri cost after bcbs? Yupelri to treat asthma?